Special Issue "Nanoparticle-Based Drug Delivery Systems"
Deadline for manuscript submissions: 30 September 2023 | Viewed by 1344
Interests: nanoparticle; cancer therapy; cancer imaging; immunotherapy; tumor microenvironment
Cancer is a leading cause of death worldwide, but new developments in nanotechnology are expected to improve the therapeutic efficacy while decreasing the side effects of anticancer drugs on healthy organs by taking advantage of the tumor microenvironment. The tumor microenvironment possesses an intricate structure and constituents that are distinct from those of normal tissues, for example, dysfunctional blood vessels, acidic pH values, excess levels of GSH, and over-expressed enzymes, which not only promote tumor angiogenesis and metastasis but are also responsible for therapeutic resistance and treatment failure. Nanomedicines, based on organic, inorganic, lipid, protein, or glycan compounds as well as on synthetic polymers, have been designed to change their physicochemical property once they arrive at the tumor site and are triggered by the tumor microenvironment to increase cancer therapeutic outcome, reverse the multidrug resistance of cancer, inhibit tumor angiogenesis, etc.
Nanoparticles also hold considerable promise in biomedical imaging, which is indispensable for assessing therapeutic intervention and reflecting the dynamic changes of cancer. For example, macroscopic imaging can measure lesion size, lesion metabolism, metastasis, etc.
This Special Issue is designed to gather scientific papers on nanomedicines for cancer treatment. Potential topics may include (but are not limited to): i) nanomedicine in cancer therapy; ii) nanomedicine in cancer imaging; iii) nanomedicine-based cancer immunotherapy.
Dr. Yapei Zhang
Prof. Dr. Zhi Yuan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cancer therapy
- cancer imaging
- tumor microenvironment